Invesaro

Stocks PTC Financial statements

Financial statements

PTC INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PTC INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,1411,1641,2421,2561,4581,8071,9332,0972,2982,739
Cost of revenue326329326325334371386441445445
Gross profit8158369159301,1241,4361,5471,6561,8542,294
Research and development229236250247257300339394433458
Selling and marketing367373415417435518485530559567
General and administrative146145143128160206205234232226
Operating expenses8438679131,0551,1001,1981,2661,312
Operating income-3741.872.663211381447458588982
Interest expense29.942.441.74376.450.554.312912077
Interest income3.443.253.82
Other non-operating income-30.2-0.77-2.280.310.2761.543.510.5514.8
Pre-tax income-67.2-1.4128.720.3135392397333469920
Income tax-12.7-7.65-23.347.84.01-85.2848792.6186
Net income-54.56.2452-27.5131477313246376734
EBITDA49.51291601412924665355636961,085
EPS, basic-0.480.050.45-0.231.134.082.672.073.146.12
EPS, diluted-0.480.050.44-0.231.124.032.652.063.126.08
Shares, basic (weighted)115116116118116117117118120120
Shares, diluted (weighted)115117118118116118118119121121

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents278280260270275327272288266184
Receivables1611521293734155416378118621,001
Other current assets13216617059.745.213571.181.86878.8
Total current assets6436676347838331,0731,0691,2771,2991,383
Property, plant and equipment67.163.680.610610110098.188.475.260.8
Lease right-of-use assets0150152138143133115
Goodwill1,1701,1831,1821,2381,6262,1922,3543,3593,4623,493
Intangible assets310258200170238379383941897825
Other non-current assets35.334.536.3140213313390357358546
Total assets2,3462,3602,3292,6653,3834,5084,6876,2896,3846,617
Accounts payable1835.253.542.424.933.440.243.524.211.5
Accrued liabilities14611110288.8101118104160174200
Deferred revenue400446488386417482504665754812
Short-term debt009.3852125
Total current liabilities6556797356386817797921,6711,6671,237
Lease liabilities0180181168168158148
Other non-current liabilities7053.158.410255.949.735.839.863.8188
Total liabilities1,5031,4751,4541,4631,9442,4692,3913,6123,1692,791
Total debt6436691,0051,4391,3511,6861,2271,172
Paid-in capital1,5991,6091,5581,5031,6031,7191,7211,8211,9651,823
Retained earnings-657-651-599-191-62.34157289731,3502,084
Other comprehensive income-100-73.9-85.6-111-103-95.9-153-118-102-81.2
Shareholders' equity8438858751,2021,4382,0382,2962,6773,2143,826
Total equity8438858751,2021,4382,0382,2962,6773,2143,826
Total liabilities and equity2,3462,3602,3292,6653,3834,5084,6876,2896,3846,617
Shares outstanding115115118115116117117119120120

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-54.56.2452-27.5131477313246376734
Depreciation and amortization86.686.787.477.880.885.287.7105108103
Stock-based compensation6676.782.986.4115177175206223216
Deferred income tax-44.2-28.3-56.61.71-24.6-1584316.7-39-26.3
Change in receivables52.612.820.429.4-32.4-119-165-98.6-34.6-121
Change in payables-14.220.35.2516.2-5.1425.16.9615.9-24.4-0.64
Cash from operations183135248285234369435611750868
Capital expenditures-26.2-25.4-36-64.4-20.2-24.7-19.5-23.8-14.4-11
Acquisitions-166-4.96-3-86.7-483-718-283-828-93.5-6.53
Purchases of investments-0.560-1-7.5-33.9-7.5600
Sales and maturities of investments015.200
Cash from investing-237-16.1-49.2-150-526-688-201-866-125-38.3
Debt issued001,00000
Debt repaid00-5000000-500
Stock issued0.0210.81,0161318.421.621.221.725.726.1
Share buybacks0-51-1,100-1150-30-12500-300
Cash from financing51.6-118-211-123297370-264268-651-909
Exchange rate effect6.811.07-7.81-2.570.03-0.13
Net change in cash4.522.04-20.19.65.2751.1-54.215.9-22.3-81.5
Free cash flow157110212221214344416587736857
Income taxes paid25.535.422.638.952.6565565.968.6122

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $138.12 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin84.5%Gross profit / revenue.
Operating margin37.8%Operating income / revenue.
EBITDA margin41.2%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin51.8%Pre-tax income / revenue.
Net margin41.4%Net income / revenue.
FCF margin31.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin32.3%Cash from operations / revenue.
Effective tax rate20.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)35.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)18.8%Net income / average total assets.
Return on invested capital (ROIC)19.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue16.1%Research and development expense / revenue.
Stock-based pay / revenue8.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.7%Capital expenditures / revenue.
D&A / revenue3.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y19.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y12.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y13.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y23.8%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y14.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y15.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y67.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y30.0%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y36.0%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y55.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y26.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y30.0%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y95.0%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y32.8%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y41.2%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y94.9%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y31.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y40.3%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y15.7%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y25.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y30.0%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y16.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y27.2%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y32.0%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y19.0%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y18.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y21.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y3.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y12.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y14.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.03xCurrent assets / current liabilities.
Quick ratio0.88x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.26x(Cash + short-term investments) / current liabilities.
Debt / equity0.40xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets21.5%Total debt / total assets.
Liabilities / assets46.7%Total liabilities / total assets.
Net debt$1.05BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.86xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage17.1xOperating income / interest expense.
Working capital$33.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets63.9%(Goodwill + intangible assets) / total assets.
Tangible book value-$694.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.45xRevenue / average total assets.
Fixed asset turnover47.0xRevenue / average property, plant and equipment.
Receivables turnover3.58xRevenue / average receivables.
Days sales outstanding102 days365 x average receivables / revenue.
Days payables28 days365 x average accounts payable / cost of revenue.
FCF conversion76.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow2.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$10.64Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$25.69Revenue / diluted weighted shares.
FCF per share$8.14Free cash flow / diluted weighted shares.
Operating cash flow per share$8.31Cash from operations / diluted weighted shares.
Book value per share$31.34Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$6.27Tangible book value / shares outstanding.
Cash per share$3.17(Cash + short-term investments) / shares outstanding.
Buybacks / FCF149.8%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$14.99BShare price x shares outstanding.
Enterprise value$16.03BMarket cap + total debt - cash - short-term investments.
P/E12.2xMarket cap / net income. Only when net income is positive.
P/S5.07xMarket cap / revenue.
P/B4.32xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF16.0xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF15.7xMarket cap / cash from operations, when positive.
EV/Sales5.43xEnterprise value / revenue.
EV/EBIT14.4xEnterprise value / operating income, when both are positive.
EV/EBITDA13.2xEnterprise value / EBITDA, when both are positive.
EV/FCF17.1xEnterprise value / free cash flow, when both are positive.
FCF yield6.2%Free cash flow / market cap.
Earnings yield8.2%Net income / market cap (the inverse of P/E).
Shareholder yield9.3%(Dividends paid + share buybacks) / market cap.
PEG0.38xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was PTC INC.'s revenue in fiscal 2025?

PTC INC. reported revenue of $2.74B for fiscal 2025, 19.2% higher than the year before.

Was PTC INC. profitable in fiscal 2025?

Yes. Net income was $734.0M, a net margin of 26.8%.

How much free cash flow did PTC INC. generate in fiscal 2025?

Cash from operations of $867.7M minus capital expenditures of $11.0M left free cash flow of $856.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PTC INC.